You have access
BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells
David J. Lamb, Stefan Lutz Wollin, Andreas Schnapp, Daniel Bischoff, Klaus J. Erb, Thierry Bouyssou, Bernd Guilliard, Christine Strasser, Eva Wex, Sylvia Blum, Eva Thaler, Helga Nickel, Oliver Radmacher, Hannah Haas, Jennifer L. Swantek, Don Souza, Melissa Canfield, Della White, Mark Panzenbeck, Mohammed A. Kashem, Mary Sanville-Ross, Takeshi Kono, Katherina Sewald, Armin Braun, Helena Obernolte, Olga Danov, Gerhard Schaenzle, Georg Rast, Gerd-Michael Maier and Matthias Hoffmann
Journal of Pharmacology and Experimental Therapeutics June 2016, 357 (3) 554-561; DOI: https://doi.org/10.1124/jpet.116.233155